F

Ferring Pharmaceuticals

Develops peptide hormone-based medicines and therapies

Operator Sterile Production

Bioprocess & BiomanufacturingUpdated on Nov 9
Full-timeKiel, GermanyIn-person

About the Job

Requirements

  • Completed vocational training as a pharmaceutical technician, chemical technician, or a comparable qualification in a technically oriented profession such as chemistry, biology, pharmacy, medicine, or food technology.
  • Openness to technical processes and practical aptitude for operating production equipment.
  • High standards of cleanliness and hygiene.
  • Independent, reliable, and conscientious work habits.
  • Very good knowledge of GMP-compliant documentation and cleanroom conduct.
  • Good spoken and written German and English.
  • Confident use of Microsoft Office, especially Excel and Outlook.
  • Ability to work collaboratively with a team.
  • Availability for different working-time models, including shift work and weekend work.

Responsibilities

  • Prepare materials and equipment for production.
  • Operate complex production equipment.
  • Machine-fill sterile medicines in a cleanroom.
  • Fully document all work processes.
  • Assist with maintenance of machines and equipment.
  • Assist in creating and maintaining work instructions.
  • Record production orders in the inventory management system.
  • Safely handle highly potent substances.

Desired Qualifications

  • Initial professional experience in the manufacture of sterile medicines is desirable.

About the Company

Ferring Pharmaceuticals

Develops peptide hormone-based medicines and therapies

Ferring Pharmaceuticals develops medicines that use the body's own peptide hormones, focusing on specialties such as reproductive health, gastroenterology, and urology. Its products range from hormone-based therapies to newer gene-based treatments, such as Adstiladrin for bladder cancer. The company achieves its solutions through research-driven development and manufacturing, including synthetic production of peptide hormones (historically oxytocin and vasopressin) and ongoing expansion of production and clinical programs. Ferring differentiates itself by remaining privately held to pursue a long-term research vision, growing through organic expansion and strategic acquisitions while maintaining a global footprint (over 100 countries, 7,000+ employees). Its goal is to advance therapies that leverage the body's biology to treat diseases more effectively, supported by a sustained investment in R&D and manufacturing, with a future focus on bioengineered and gene-based approaches.

Company size
5,001-10,000
Company stage
Debt Financing
Total funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950

Recently Posted Jobs

Explore more opportunities at Ferring Pharmaceuticals

See more jobs